Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Thymidine kinase expression. A marker for malignant cells

M Hengstschläger1, M Pfeilstöcker, E Wawra

  • 1Institute of Molecular Biology, University of Vienna, Vienna Biocenter, Austria.

Advances in Experimental Medicine and Biology
|May 23, 1998
PubMed
Summary

A new assay detects thymidine kinase (TK) levels in single cells, distinguishing malignant cells from normal ones. This method identifies leukemia cells in blood and bone marrow samples.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Refinement of intermediate-risk Karyotypes according to the IPSS-R in patients with myelodysplastic neoplasms (MDS).

Annals of hematology·2025
Same author

The new WHO 2022 and ICC proposals for the classification of myelodysplastic neoplasms. Validation based on the Düsseldorf MDS Registry and proposals for a merged classification.

Leukemia·2024
Same author

IL1R1<sup>+</sup> cancer-associated fibroblasts drive tumor development and immunosuppression in colorectal cancer.

Nature communications·2023
Same author

Prognostic factors and follow-up parameters in patients with paroxysmal nocturnal hemoglobinuria (PNH): experience of the Austrian PNH network.

Annals of hematology·2020
Same author

Therapy-related myelodysplastic syndromes deserve specific diagnostic sub-classification and risk-stratification-an approach to classification of patients with t-MDS.

Leukemia·2020
Same author

The IPSS-R has prognostic impact in untreated patients with MDS del(5q).

Leukemia research·2018

Area of Science:

  • Biochemistry
  • Cell Biology
  • Oncology

Background:

  • Thymidine kinase (TK) is crucial for DNA synthesis and typically regulated during the cell cycle.
  • Malignant cells exhibit significantly higher and sustained TK expression compared to normal cells.

Purpose of the Study:

  • To develop and validate a novel cytofluorometric assay for quantifying single-cell thymidine kinase (TK) activity.
  • To differentiate between normal, virally transformed, and malignant cells based on TK expression levels.

Main Methods:

  • Development of a cytofluorometric assay to measure thymidine kinase (TK) activity in individual cells.
  • Application of the assay to analyze blood and bone marrow samples from leukemia patients.
  • Assessment of TK expression in cell cultures representing a tumor progression model.

Related Experiment Videos

Main Results:

  • The assay successfully discriminated between normal and malignant cells, including virally transformed cells and tumor cell lines.
  • Leukemic cells were identified within mixed populations of normal leukocytes in patient samples.
  • Enhanced TK fluorescence was observed only in advanced, malignant stages of tumor progression, while benign tumor cells showed normal levels.

Conclusions:

  • The novel cytofluorometric TK assay is effective for identifying and characterizing malignant cells.
  • This assay has potential applications in diagnosing and monitoring hematological malignancies like leukemia.
  • The findings support TK as a reliable biomarker for distinguishing benign from malignant cellular proliferation.